Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Weber

Showing results (291-300 of 316) with videos related to

Pageof 32
Sort By:
Brain : a Journal of Neurology|October 16, 2019
Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutationsDavid Brenner, Angela Rosenbohm, Rüstem Yilmaz, et al.
Annals of Neurology|January 3, 2021
The Effect of SMN Gene Dosage on ALS Risk and Disease SeverityMatthieu Moisse, Ramona A J Zwamborn, Joke van Vugt, et al.
Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Frontiers in Cellular Neuroscience|March 20, 2023
Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survivalBrett N Adey, Johnathan Cooper-Knock, Ahmad Al Khleifat, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 13, 2025
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsAlfredo Iacoangeli, Allison A Dilliott, Ahmad Al Khleifat, et al.
Neurological Research and Practice|August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 5, 2017
July 2017 ENCALS statement on edaravoneAmmar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, et al.
Annals of Neurology|June 17, 2014
C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysisFrank P Diekstra, Vivianna M Van Deerlin, John C van Swieten, et al.
Brain : a Journal of Neurology|April 12, 2023
Genetic variability in sporadic amyotrophic lateral sclerosisSien Hilde Van Daele, Matthieu Moisse, Joke J F A van Vugt, et al.
Pageof 32

Showing results (291-300 of 316) with videos related to

Sort By:
Pageof 32
Brain : a Journal of Neurology|October 16, 2019
Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutationsDavid Brenner, Angela Rosenbohm, Rüstem Yilmaz, et al.
Annals of Neurology|January 3, 2021
The Effect of SMN Gene Dosage on ALS Risk and Disease SeverityMatthieu Moisse, Ramona A J Zwamborn, Joke van Vugt, et al.
Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Frontiers in Cellular Neuroscience|March 20, 2023
Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survivalBrett N Adey, Johnathan Cooper-Knock, Ahmad Al Khleifat, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 13, 2025
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsAlfredo Iacoangeli, Allison A Dilliott, Ahmad Al Khleifat, et al.
Neurological Research and Practice|August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 5, 2017
July 2017 ENCALS statement on edaravoneAmmar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, et al.
Annals of Neurology|June 17, 2014
C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysisFrank P Diekstra, Vivianna M Van Deerlin, John C van Swieten, et al.
Brain : a Journal of Neurology|April 12, 2023
Genetic variability in sporadic amyotrophic lateral sclerosisSien Hilde Van Daele, Matthieu Moisse, Joke J F A van Vugt, et al.
Pageof 32